Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD4

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Related Keywords

China , Taiwan , United States , Hong Kong , Macau , Suzhou , Jiangsu , Rhui Zhou , Guangdong , American , Innovent Biologics , Selpercatinib Eli Lilly , Adimab Incyte , Miao , Eli Lilly , American Society Of Hematology , First Affiliated Hospital Of Suzhou University , Prnewswire Innovent Biologics Inc , Md Anderson Cancer Center , Incyte Corporation , Annual Meeting , Updated Results , Objective Response Rate , First Affiliated Hospital , Suzhou University , Senior Vice President , Mainland China , Main Board , Stock Exchange , Hong Kong Limited , Cancer Center ,